Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1314-1326

  Charni, Faten ^a   Friand, Veronique ^a   Haddad, Oualid ^a   Hlawaty, Hanna ^a   Martin, Loïc ^b   Vassy, Roger ^a   Oudar, Olivier ^a   Gattegno, Liliane ^a,c   Charnaux, Nathalie ^a,c   Sutton, Angela ^a,c  

^a UNIVERSITÉ PARIS 13   (France)

^b CEA SACLAY   (France)

^c HÔPITAL JEAN VERDIER   (France)

Author keywords

Chemokine; Chemotaxis; Hepatocellular carcinoma; RANTES CCL5; Spreading; Syndecan

Indexed keywords

ARGININE; FOCAL ADHESION KINASE; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RANTES; RHO KINASE; SYNDECAN 1; SYNDECAN 4;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANTHRACENES; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL5; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; FLOW CYTOMETRY; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; SYNDECAN-1; SYNDECAN-4;

EID: 69949094934     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.015     Document Type: Article

References (44)

1. Gerard C., and Rollins B.J. Chemokines and disease. Nat. Immunol. 2 (2001) 108-115
2. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
3. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
4. Martin L., Blanpain C., Garnier P., Wittamer V., Parmentier M., and Vita C. Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 40 (2001) 6303-6318
5. Proudfoot A.E. The biological relevance of chemokine-proteoglycan interactions. Biochem. Soc. Trans. 34 (2006) 422-426
6. Proudfoot A.E., Fritchley S., Borlat F., et al. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276 (2001) 10620-10626
7. Proudfoot A.E., Handel T.M., Johnson Z., et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1885-1890
8. Slimani H., Charnaux N., Mbemba E., et al. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. Glycobiology 13 (2003) 623-634
9. Slimani H., Charnaux N., Mbemba E., et al. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. Biochim. Biophys. Acta 1617 (2003) 80-88
10. Charnaux N., Brule S., Chaigneau T., et al. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44. Glycobiology 15 (2005) 119-130
11. Sutton A., Friand V., Papy-Garcia D., et al. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. Mol. Cancer Ther. 6 (2007) 2948-2958
12. Appay V., Brown A., Cribbes S., Randle E., and Czaplewski L.G. Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants. J. Biol. Chem. 274 (1999) 27505-27512
13. Baltus T., Weber K.S., Johnson Z., Proudfoot A.E., and Weber C. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102 (2003) 1985-1988
14. Ali S., Fritchley S.J., Chaffey B.T., and Kirby J.A. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology 12 (2002) 535-543
15. Sutton A., Friand V., Brule-Donneger S., et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol. Cancer Res. 5 (2007) 21-33
16. Charnaux N., Brule S., Hamon M., et al. Syndecan-4 is a signalling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12. FEBS J. 272 (2005) 1937-1951
17. Vita C., Drakopoulou E., Ylisastigui L., et al. Synthesis and characterization of biologically functional biotinylated RANTES. J. Immunol. Methods 266 (2002) 53-65
18. Czaplewski L.G., McKeating J., Craven C.J., et al. Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J. Biol. Chem. 274 (1999) 16077-16084
19. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36 (1997) 13570-13578
20. Lu P., Nakamoto Y., Nemoto-Sasaki Y., Fujii C., Wang H., Hashii M., Ohmoto Y., Kaneko S., Kobayashi K., and Mukaida N. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am. J. Pathol. 162 (2003) 1249-1258
21. Davila J.A., Morgan R.O., Shaib Y., McGlynn K.A., and El-Serag H.B. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127 (2004) 1372-1380
22. Roskams T., De Vos R., David G., Van Damme B., and Desmet V. Heparan sulphate proteoglycan expression in human primary liver tumours. J. Pathol. 185 (1998) 290-297
23. Wu X., Fan J., Wang X., et al. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochem. Biophys. Res. Commun. 355 (2007) 866-871
24. Yang X., Lu P., Fujii C., et al. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int. J. Cancer 118 (2006) 1869-1876
25. Apolinario A., Majano P.L., Alvarez-Perez E., et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am. J. Gastroenterol. 97 (2002) 2861-2870
26. Kusano F., Tanaka Y., Marumo F., and Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab. Invest. 80 (2000) 415-422
27. Burns J.M., Gallo R.C., DeVico A.L., and Lewis G.K. A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signalling. J. Exp. Med. 188 (1998) 1917-1927
28. Bacon K.B., Premack B.A., Gardner P., and Schall T.J. Activation of dual T cell signalling pathways by the chemokine RANTES. Science 269 (1995) 1727-1730
29. Gotte M. Syndecans in inflammation. FASEB J. 17 (2003) 575-591
30. Li H.G., Xie D.R., Shen X.M., Li H.H., Zeng H., and Zeng Y.J. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J. Gastroenterol. 11 (2005) 1445-1451
31. Matsumoto A., Ono M., Fujimoto Y., Gallo R.L., Bernfield M., and Kohgo Y. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int. J. Cancer 74 (1997) 482-491
32. Chai T.Y., Chen G.G., and Lai P.B. Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J. 10 (2004) 190-200
33. Baraz L., Haupt Y., Elkin M., Peretz T., and Vlodavsky I. Tumor suppressor p53 regulates heparanase gene expression. Oncogene 25 (2006) 3939-3947
34. Vlodavsky I., Goldshmidt O., Zcharia E., Atzmon R., Rangini-Guatta Z., Elkin M., Peretz T., and Friedmann Y. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin. Cancer Biol. 12 (2002) 121-129
35. Tkachenko E., Rhodes J.M., and Simons M. Syndecans: new kids on the signalling block. Circ. Res. 96 (2005) 488-500
36. Bass M.D., Morgan M.R., Roach K.A., Settleman J., Goryachev A.B., and Humphries M.J. p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4. J. Cell. Biol. 181 (2008) 1013-1026
37. Bass M.D., and Humphries M.J. Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem. J. 368 (2002) 1-15
38. Giannone G., Dubin-Thaler B.J., Rossier O., et al. Lamellipodial actin mechanically links myosin activity with adhesion-site formation. Cell 128 (2007) 561-575
39. Kawai T., Seki M., Hiromatsu K., et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J. Immunol. 163 (1999) 3269-3278
40. Di Marzio P., Dai W.W., Franchin G., Chan A.Y., Symons M., and Sherry B. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem. Biophys. Res. Commun. 331 (2005) 909-916
41. Weiss-Haljiti C., Pasquali C., Ji H., et al. Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signalling in chemokine-induced macrophage migration. J. Biol. Chem. 279 (2004) 43273-43284
42. Saoncella S., Echtermeyer F., Denhez F., et al. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2805-2810
43. Huang C.Y., Fong Y.C., Lee C.Y., et al. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem. Pharmacol. 77 (2009) 794-803
44. Brill A., Hershkoviz R., Vaday G.G., Chowers Y., and Lider O. Augmentation of RANTES-induced extracellular signal-regulated kinase mediated signalling and T cell adhesion by elastase-treated fibronectin. J. Immunol. 166 (2001) 7121-7127